U.S. Markets closed

Top Ranked Momentum Stocks to Buy for January 22nd

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, January 22nd:

Cherokee Inc. (CHKE): This fashion and lifestyle products retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 25% over the last 60 days.

Cherokee Inc. Price and Consensus

Cherokee Inc. Price and Consensus

Cherokee Inc. price-consensus-chart | Cherokee Inc. Quote

Cherokee’s shares gained 29.5% over the last one month more than S&P 500’s gain of 8.2%. The company possesses a Momentum Score of B.

Cherokee Inc. Price

Cherokee Inc. Price

Cherokee Inc. price | Cherokee Inc. Quote

Genesco Inc. (GCO): This footwear and apparel retailer has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.9% over the last 60 days.

Genesco Inc. Price and Consensus

Genesco Inc. Price and Consensus

Genesco Inc. price-consensus-chart | Genesco Inc. Quote

Genesco’s shares gained 13.1% over the last one month. The company possesses a Momentum Score of A.

Genesco Inc. Price

Genesco Inc. Price

Genesco Inc. price | Genesco Inc. Quote

The Simply Good Foods Company (SMPL): This nutritional food and snack developer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.3% over the last 60 days.

The Simply Good Foods Company Price and Consensus

The Simply Good Foods Company Price and Consensus

The Simply Good Foods Company price-consensus-chart | The Simply Good Foods Company Quote

Simply Good Foods’ shares gained 13.7% over the last one month. The company possesses a Momentum Score of B.

The Simply Good Foods Company Price

The Simply Good Foods Company Price

The Simply Good Foods Company price | The Simply Good Foods Company Quote

AC Immune SA (ACIU): This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.

AC Immune SA Price and Consensus

AC Immune SA Price and Consensus

AC Immune SA price-consensus-chart | AC Immune SA Quote

AC Immune’s shares gained 18% over the last one month. The company possesses a Momentum Score of B.

AC Immune SA Price

AC Immune SA Price

AC Immune SA price | AC Immune SA Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Looking for Stocks with Skyrocketing Upside?

Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.

Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.

See the pot trades we're targeting>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Genesco Inc. (GCO) : Free Stock Analysis Report
 
Cherokee Inc. (CHKE) : Free Stock Analysis Report
 
AC Immune SA (ACIU) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research